Exemestane in primary breast cancer patients who are eligible to receive neoadjuvant hormonal therapy

dc.contributor.author	Sancho Pérez, Blanca
dc.contributor.author	González Blanco, Ignacio
dc.contributor.author	Noguero Meseguer, María Rosario
dc.contributor.author	García García, Ana María
dc.contributor.author	Gómez Gutiérrez, Luis Tomás
dc.contributor.author	Martín Mateos, Maximina
dc.contributor.author	Luján Alcalde, Salvador
dc.contributor.author	Albaina Latorre, Luis Pablo
dc.contributor.author	Pablo Lozano, José Luis de
dc.contributor.author	Hernández Cortés, Gínés
dc.date.accessioned	2013-01-30T10:00:15Z
dc.date.available	2013-01-30T10:00:15Z
dc.date.issued	2010
dc.identifier.citation	European Journal of Cancer Supplements, 8(3), p.75 (2010); doi:10.1016/S1359-6349(10)70089-6	spa
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10651/6855
dc.format.extent	p. 75	spa
dc.language.iso	eng
dc.relation.ispartof	European Journal of Cancer	spa
dc.rights	(c) European Journal of Cancer
dc.source	WOK	spa
dc.title	Exemestane in primary breast cancer patients who are eligible to receive neoadjuvant hormonal therapy	spa
dc.type	journal article
dc.identifier.local	20100252	spa
dc.identifier.doi	10.1016/S1359-6349(10)70089-6
dc.relation.publisherversion	https://doi.org/10.1016/S1359-6349(10)70089-6

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.